News
Proton Pump Inhibitor Use May Up Death Risk
The authors found that compared to the use of H2RA therapy, patients initiated on PPI therapy had a 25% increased risk of death (hazard ratio [HR] 1.25, 95% CI: 1.23-1.28).
Your search for proton pump inhibitor returned 31 results
News
Do PPIs Protect Against Dysplasia, Cancer in Barrett’s Esophagus?
In patients with Barrett's esophagus, use of proton pump inhibitors (PPIs) did not lead to dysplasia- or cancer-protective effects.
AASLD 2016
Long-term PPI Use Reduces Bleeding-Related Mortality in Cirrhosis Patients
Long-term use of proton pump inhibitors (PPIs) reduces bleeding-related mortality in patients with cirrhosis and variceal bleeding, a prospective study reported at The Liver Meeting® 2016.
IDWEEK 2016 - Adult Infectious Diseases
PPIs and Gastroenteritis Hospitalization: What’s the Risk?
Use of proton pump inhibitors (PPIs) was tied to a higher risk of infectious gastroenteritis hospitalization with increasing risk among increasing doses.
News
Yosprala Launched for Secondary Prevention of CV Events in Ulcer-Risk Patients
Yosprala combines aspirin, an antiplatelet, and omeprazole, a proton pump inhibitor.
News
Myopathy: Another Side Effect of PPIs?
Limited research published in Annals of Pharmacotherapy suggests that use of proton pump inhibitors (PPI) is associated with myopathy-like symptoms without long-term effects after discontinuation.
News
Are PPI Users at Risk for Vitamin B12 Deficiency?
Proton pump inhibitors (PPIs) were associated with a higher risk of inducing vitamin B12 deficiency than histamine-2 receptor antagonists (H2RAs) but longer prospective studies are needed to confirm this finding, study authors concluded in the Journal of Pharmacy Practice.
News
Common GERD Meds May Speed Up Vascular Aging
A team of researchers from Houston Methodist Research Institute reported that chronic use of proton pump inhibitors (PPIs) may accelerate vascular aging, which can lead to greater cardiovascular disease, vascular dementia, and renal failure.
News
Some Antacids Linked to Heart Attack Risk
Use of proton pump inhibitors (PPIs) increase the risk of an adult experiencing a heart attack by 16 to 21 percent compared to those who don't use commonly prescribed antacids, a large study has found.
News
Infant PPI Use and Lung Infection Risk: Is There a Link?
The data showed matched odds ratio for current vs past use of PPIs to be 0.88 (95% CI, 0.36 to 2.16) when comparing cases and their controls for community-acquired pneumonia. With regard to lower respiratory tract infections, the matched odds ratio between cases and their controls was 1.13 (95% CI, 0.87 to 1.48).
